Browse

Here is some of what you may have missed from the world's largest cancer research meeting.

At the world's largest cancer research meeting, new data were plentiful. But this year, there was also a focus on grief.

It's the second attempt for the rare disease company, which initially announced plans to merge with Candid Therapeutics before the immune drug developer was bought by UCB.